Welcome to SBW/Toxis
SBW/Toxis is a part of SBW Corporation performing preclinical in vivo pharmacology for drug discovery and development, biomaterials, food ingredient and chemical safety companies. SBW/Toxis core competencies are large spectrum of in in vivo disease models, safety pharmacology and toxicology, and pharmacokinetics studies. All SBW/Toxis studies are always tailored for the customer’s need.
Our mission is to reduce time-to-market and cost-of-development of drugs by helping our customers • to understand the efficacy, kinetics and safety of their lead molecules • to choose competent drug candidates timely and • improving success rate in the development
We follow strictly the 3R principle of Reduce-Refine-Replace. Animal well-being is an intrinsic part of our daily work. Only human methods and euthanasia are used in our services.
To existing Toxis customers: the original Toxis www site is no longer active, you can find all the Toxis services and expertise in this site, presenting the whole SBW group. We are happy help, please contact us form this link (emails, phone number etc.).